PER percheron therapeutics limited
Add to My Watchlist 13.6% ! 1.0¢

Ann: Percheron launches post-trial access program, page-101

  1. qwert0
    670 Posts.
    lightbulb Created with Sketch. 352
    clock Created with Sketch.
    11/11/24
    13:47
    Post #: 76547395
    I guess you can never have too many potential partners lined up ready to negotiate. No reason to sign the first offer we receive.

    Assuming that results are positive, the longer we can hold out the stronger our negotiating position.
    PER Price at posting: 8.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Expert Exchange: Laretive's 4 key strategies to picking ASX winners
right-arrow Created with Sketch.
AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.
NEWS DroneShield's civilian counter-drone tech lands with a buzz
right-arrow Created with Sketch.
NEWS RBA's inflation trick: Is the number lying to us?
right-arrow Created with Sketch.
NEWS Lithium hype is back. Just ignore the fact Jianxiawo only supplies 3% globally
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.0¢ 		Change
-0.002(13.6%) 		Mkt cap ! $10.33M
Open High Low Value Volume
1.1¢ 1.1¢ 1.0¢ $33.35K 3.267M

Buyers (Bids)

No. Vol. Price($)
1 99999 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 234250 3
View Market Depth
Last trade - 12.49pm 11/08/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.